Last reviewed · How we verify
NCT02789748: EKINOx
PErsonalized and Adaptive Kinesthetic stImulation Therapy, Based on Cardio-respiratory Holter moNitoring, for Sleep Apnea syndrOmes
NA trial testing Kinesthetic stimulation in Obstructive Sleep Apnea Syndrome in 42 participants. Completed in 2 October 2017.
2 October 2017
Quick facts
| Lead sponsor | LivaNova |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 42 |
| Start date | 1 June 2016 |
| Primary completion | 2 October 2017 |
| Estimated completion | 2 October 2017 |
| Sites | 4 locations across France |
Drugs / interventions tested
- Kinesthetic stimulation
Conditions studied
- Obstructive Sleep Apnea Syndrome — all drugs for Obstructive Sleep Apnea Syndrome →
Sponsor
LivaNova — full company profile →
Who can join
18 and older, any sex, with Obstructive Sleep Apnea Syndrome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims at quantifying the performance of kinesthetic stimulation to reduce the burden of obstructive sleep apneas and hypopneas.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Kinesthetic stimulation for obstructive sleep apnea syndrome: An "on-off" proof of concept trial.
Hernández AI, Pérez D, Feuerstein D, Loiodice C, et al · · 2018 · cited 3× · PMID 29449609 · DOI 10.1038/s41598-018-21430-w
Verify or expand the search:
- PubMed search for NCT02789748
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Kinesthetic stimulation
Trials testing the same drug.
- NCT03300037 — HYpopnea and Apnea Detection and Treatment Performance of a New cardiOreSpiratory Holter Monitor · completed
Other recruiting trials for Obstructive Sleep Apnea Syndrome
Currently open trials in the same condition.
- NCT05147649 — Functional Magnetic Resonance Imaging in Patients With Obstructive Sleep Apnea Syndrome · NA · recruiting
Other LivaNova trials
Trials by the same sponsor.
- NCT05975931 — IMPACT of AspireSR® for VNS Therapy on Healthcare Resource Utilisation and Clinical Outcomes. · terminated
- NCT04950894 — Treating Obstructive Sleep Apnea Using Targeted Hypoglossal Neurostimulation · NA · active not recruiting
- NCT04779814 — Non-interventional Study Describing Healthcare Resource Utilisation and Clinical Outcomes Associated With VNS Therapy in · terminated
- NCT04753385 — The RECOVER sUb-study, Which Leverages quaNtitative and Credible Research tOols From Verily, Will providE Assessment mea · terminated
- NCT04282681 — XLTCS - Accelerometer Data Collection in an Epilepsy Monitoring Unit (EMU) · withdrawn
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02789748 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by LivaNova
- Last refreshed: 5 October 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02789748.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing